Delivery Order SPE2DB22D1106-SPE2DB25FEGP0
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,973.32, is for the supply of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of June 20, 2024 and is a firm-fixed-price delivery order. The contract is not designated as a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,292.74 contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm-fixed price pricing type and an ultimate completion date of December 12, 2023. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,123.75 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,737.06 firm-fixed-price contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $4,598.40 and a completion date of May 12, 2025. It is a firm fixed-price contract, meaning the price will not change regardless of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,268.24, is for the delivery of VYVANSE 30 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price delivery order with a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,215.85, is for the supply of VYVANSE 60 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $3,510.68 and is a firm fixed-price delivery order contract, with a period of performance through November 19, 2024. The contract is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,531.16, is for the delivery of VYVANSE 50 MG CAPSULES 100S to support federal healthcare programs. The contract is a Firm Fixed Price delivery order with a completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,801.92, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...